Paper40134377
Progress of research on engineered extracellular vesicles from different sources for disease treatment.
Kang J and 4 others. Histol Histopathol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Progress of research on engineered extracellular vesicles from different sources for disease treatment. Papers, record 40134377. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40134377
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Progress of research on engineered extracellular vesicles from different sources for disease treatment.
- PubMed
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extracellular Vesicles | Major topic |
| Humans | |
| Animals |
Source PubMed
References183
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30692670 | Exploitation of the Leishmania exosomal pathway by Leishmania RNA virus 1. | Nat Microbiol | 2019 | https://conductscience.org/library/papers/30692670 | PubMed |
| 2 | 35421371 | VAP-A and its binding partner CERT drive biogenesis of RNA-containing extracellular vesicles at ER membrane contact sites. | Dev Cell | 2022 | https://conductscience.org/library/papers/35421371 | PubMed |
| 3 | 23344721 | miR-1289 and "Zipcode"-like Sequence Enrich mRNAs in Microvesicles. | Mol Ther Nucleic Acids | 2012 | https://conductscience.org/library/papers/23344721 | PubMed |
| 4 | 34773385 | Growth Media Conditions Influence the Secretion Route and Release Levels of Engineered Extracellular Vesicles. | Adv Healthc Mater | 2022 | https://conductscience.org/library/papers/34773385 | PubMed |
| 5 | 39048489 | Next-generation cancer vaccines and emerging immunotherapy combinations. | Trends Cancer | 2024 | https://conductscience.org/library/papers/39048489 | PubMed |
| 6 | 30316791 | Preservation of exosomes at room temperature using lyophilization. | Int J Pharm | 2018 | https://conductscience.org/library/papers/30316791 | PubMed |
| 7 | 31858807 | Bioengineering Bacterial Vesicle-Coated Polymeric Nanomedicine for Enhanced Cancer Immunotherapy and Metastasis Prevention. | Nano Lett | 2020 | https://conductscience.org/library/papers/31858807 | PubMed |
| 8 | 34202555 | Combining Augmented Radiotherapy and Immunotherapy through a Nano-Gold and Bacterial Outer-Membrane Vesicle Complex for the Treatment of Glioblastoma. | Nanomaterials (Basel) | 2021 | https://conductscience.org/library/papers/34202555 | PubMed |
| 9 | 37589312 | Fruit-Derived Extracellular-Vesicle-Engineered Structural Droplet Drugs for Enhanced Glioblastoma Chemotherapy. | Adv Mater | 2023 | https://conductscience.org/library/papers/37589312 | PubMed |
| 10 | 38155418 | Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance. | Cancer Commun (Lond) | 2024 | https://conductscience.org/library/papers/38155418 | PubMed |
| 11 | 38500170 | Engineered extracellular vesicles carrying let-7a-5p for alleviating inflammation in acute lung injury. | J Biomed Sci | 2024 | https://conductscience.org/library/papers/38500170 | PubMed |
| 12 | 38992695 | Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials. | J Biomed Sci | 2024 | https://conductscience.org/library/papers/38992695 | PubMed |
| 13 | 36929005 | NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation. | Protein Cell | 2023 | https://conductscience.org/library/papers/36929005 | PubMed |
| 14 | 25088052 | Extracellular membrane vesicles secreted by mycoplasma Acholeplasma laidlawii PG8 are enriched in virulence proteins. | J Proteomics | 2014 | https://conductscience.org/library/papers/25088052 | PubMed |
| 15 | 34260047 | Biodistribution of Exosomes and Engineering Strategies for Targeted Delivery of Therapeutic Exosomes. | Tissue Eng Regen Med | 2021 | https://conductscience.org/library/papers/34260047 | PubMed |
| 16 | 31114624 | RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease. | Immun Ageing | 2019 | https://conductscience.org/library/papers/31114624 | PubMed |
| 17 | 30559414 | A whole-cell electron tomography model of vacuole biogenesis in Arabidopsis root cells. | Nat Plants | 2019 | https://conductscience.org/library/papers/30559414 | PubMed |
| 18 | 34901540 | A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis. | Bioact Mater | 2022 | https://conductscience.org/library/papers/34901540 | PubMed |
| 19 | 38440791 | Identification of potential novel proteomic markers of Leishmania spp.-derived exosomes. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/38440791 | PubMed |
| 20 | 32363014 | Protein markers for Candida albicans EVs include claudin-like Sur7 family proteins. | J Extracell Vesicles | 2020 | https://conductscience.org/library/papers/32363014 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42368581 | Engineered cell-biomimetic nanosystems for anti-inflammatory therapy: Targeting, neutralization and immunomodulation. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42368581 | PubMed |
| 42005709 | Research Progress and Preclinical Prospects of Plant-Derived Extracellular Vesicles in Targeted Delivery of Antitumor Drugs. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42005709 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40134377
GET https://conductscience.org/api/papers/v1/40134377/references?page=2